{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:28:23Z","timestamp":1784248103043,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB028741"],"award-info":[{"award-number":["P41EB028741"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32EB025823"],"award-info":[{"award-number":["T32EB025823"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA151261"],"award-info":[{"award-number":["U01CA151261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020940","name":"National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.crad.2023.12.022","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T06:07:12Z","timestamp":1705644432000},"page":"e607-e615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early change in apparent diffusion coefficient as a predictor of response to neoadjuvant androgen deprivation and external beam radiation therapy for intermediate- to high-risk prostate cancer"],"prefix":"10.1016","volume":"79","author":[{"given":"F.B.","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Leeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Fennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2023.12.022_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.crad.2023.12.022_bib2","series-title":"Key statistics for prostate cancer","author":"Society","year":"2018"},{"key":"10.1016\/j.crad.2023.12.022_bib3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.crad.2023.12.022_bib4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.6004\/jnccn.2014.0072","article-title":"Prostate cancer, version 2.2014","volume":"12","author":"Mohler","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.crad.2023.12.022_bib5","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2023.12.022_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1997.15.3.1013","article-title":"Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31","volume":"15","author":"Pilepich","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2023.12.022_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.299.3.289","article-title":"Androgen suppression and radiation versus radiation alone for prostate cancer: a randomized trial","volume":"299","author":"D\u2019Amico","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.crad.2023.12.022_bib8","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(11)61095-7","article-title":"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial","volume":"378","author":"Warde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.crad.2023.12.022_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): an open randomised phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.crad.2023.12.022_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.2005.11.148","article-title":"Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis","volume":"23","author":"Brenner","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2023.12.022_bib11","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1200\/JCO.2003.01.075","article-title":"Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era","volume":"21","author":"D\u2019Amico","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2023.12.022_bib12","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/cncr.31400","article-title":"Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy","volume":"124","author":"Bryant","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2023.12.022_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/pcan.2016.67","article-title":"End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer","volume":"20","author":"Narang","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.crad.2023.12.022_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijrobp.2016.07.009","article-title":"Posttreatment prostate-specific antigen 6 months after radiation with androgen deprivation therapy predicts for distant metastasis-free survival and prostate cancer-specific mortality","volume":"96","author":"Naik","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2023.12.022_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s13193-012-0142-6","article-title":"A review on the clinical utility of PSA in cancer prostate","volume":"3","author":"Adhyam","year":"2012","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.crad.2023.12.022_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ctrv.2016.03.016","article-title":"Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: a systematic review of the literature","volume":"46","author":"Zilli","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.crad.2023.12.022_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00261-017-1297-y","article-title":"Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer","volume":"43","author":"Hassanzadeh","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.crad.2023.12.022_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00261-018-1718-6","article-title":"Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 + 4 and 4 + 3 prostate cancer","volume":"44","author":"Alessandrino","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.crad.2023.12.022_bib19","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.juro.2018.06.041","article-title":"Multiparametric magnetic resonance imaging features identify aggressive prostate cancer at the phenotypic and transcriptomic level","volume":"200","author":"Beksac","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.crad.2023.12.022_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/JU.0000000000000134","article-title":"Defining prostate cancer at favorable intermediate risk: the potential utility of magnetic resonance imaging and genomic tests","volume":"202","author":"Falagario","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.crad.2023.12.022_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2016.06.011","article-title":"Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations\u2014a report of a European School of Oncology Task Force","volume":"71","author":"Moore","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2023.12.022_bib22","article-title":"Multiparametric MRI as a biomarker of response to neoadjuvant therapy for localized prostate cancer\u2014a pilot study","author":"Fennessy","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.crad.2023.12.022_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1593\/tlo.13922","article-title":"Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls","volume":"7","author":"Fennessy","year":"2014","journal-title":"Transl Oncol"},{"key":"10.1016\/j.crad.2023.12.022_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mrm.23062","article-title":"DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study","volume":"67","author":"Barrett","year":"2012","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.crad.2023.12.022_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1148\/radiol.11091409","article-title":"Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer","volume":"259","author":"Hambrock","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2023.12.022_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1148\/radiol.10100667","article-title":"Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?","volume":"258","author":"Turkbey","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2023.12.022_bib27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2214\/AJR.11.7805","article-title":"Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis","volume":"199","author":"Tan","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2023.12.022_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2214\/AJR.10.4441","article-title":"Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy","volume":"196","author":"Verma","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2023.12.022_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jmri.22317","article-title":"Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?","volume":"33","author":"Itou","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2023.12.022_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1148\/radiol.11102066","article-title":"Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumour detection and assessment of aggressiveness","volume":"259","author":"Vargas","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2023.12.022_bib31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jmri.23885","article-title":"Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer","volume":"37","author":"Foltz","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2023.12.022_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ijrobp.2011.06.2009","article-title":"Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer","volume":"83","author":"Park","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2023.12.022_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1756287218798748","article-title":"Changes in prostate apparent diffusion coefficient values during radiotherapy after neoadjuvant hormones","volume":"10","author":"McPartlin","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.crad.2023.12.022_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2014.07.016","article-title":"Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T","volume":"113","author":"Decker","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2023.12.022_bib35","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00330-015-3688-1","article-title":"Prostate cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI","volume":"25","author":"H\u00f6tker","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2023.12.022_bib36","doi-asserted-by":"crossref","first-page":"W645","DOI":"10.2214\/AJR.13.12277","article-title":"Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer","volume":"203","author":"Kim","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2023.12.022_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28817-9","article-title":"Diffusion weighted MRI as an early predictor of tumour response to hypofractionated stereotactic boost for prostate cancer","volume":"8","author":"Pasquier","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.crad.2023.12.022_bib38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jmri.23860","article-title":"Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer","volume":"37","author":"Hegde","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2023.12.022_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2023.12.022_bib40","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.crad.2023.12.022_bib41","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140359","article-title":"Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer","volume":"87","author":"Liu","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.crad.2023.12.022_bib42","doi-asserted-by":"crossref","first-page":"W477","DOI":"10.2214\/AJR.09.3557","article-title":"Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T","volume":"194","author":"Song","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2023.12.022_bib43","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/jmri.21388","article-title":"ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy","volume":"27","author":"Takayama","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2023.12.022_bib44","first-page":"337","article-title":"The morphologic changes induced by hormone and radiation therapy on prostate carcinoma","volume":"109","author":"Roznovanu","year":"2005","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.crad.2023.12.022_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-4295(97)00164-7","article-title":"Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy","volume":"49","author":"Reuter","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.crad.2023.12.022_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110942","article-title":"Quantification of cross-vendor variation in ADC measurements in vendor-specific prostate MRI-protocols","author":"M\u00f8ller","year":"2023","journal-title":"Eur J Radiol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:50:27Z","timestamp":1757868627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926024000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0009926024000151"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2023.12.022","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early change in apparent diffusion coefficient as a predictor of response to neoadjuvant androgen deprivation and external beam radiation therapy for intermediate- to high-risk prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2023.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}